Skip to main content
ARPA-H has awarded 25 million dollars to the VITAL project to develop 3D printed, patient-derived vascularized livers through a collaboration between UT Southwestern and Trestle Biotherapeutics.
Funding
1 min read

ARPA-H has awarded 25 million dollars to the VITAL project to develop 3D printed, patient-derived vascularized livers through a collaboration between UT Southwestern and Trestle Biotherapeutics.

Originally reported by prismedia.ai

ARPA-H has awarded 25 million dollars to the VITAL project to develop 3D printed, patient-derived vascularized livers through a collaboration between UT Southwestern and Trestle Biotherapeutics. This initiative targets the production of functional organ constructs with integrated vascular networks and bile ducts in just 10 to 13 weeks. By combining GMP-compliant manufacturing with high-resolution bioprinting, this project moves regenerative medicine toward a repeatable clinical supply chain. This systemic shift will transform organ transplant accessibility and provide high-fidelity human models for drug testing. #3DPrinting #Bioprinting #HealthTech #AdditiveManufacturing #ARPAH

Read Original

How This Connects

6 related events
  1. Same pattern

    CollPlant has launched BioFlex, a ready-to-print rhCollagen kit optimized for high-resolution Digital Light Processing (DLP) 3D bioprinting.

  2. Same pattern

    Auxilium Biotechnologies is partnering with Starlab Space to deploy the AMP-1 bioprinting platform for scalable medical manufacturing in low Earth orbit.

  3. Same pattern

    PrintBio has joined a federal consortium led by WFIRM to receive up to 24.8 million USD from ARPA-H for bioprinting vascularized kidney tissue.

  4. Same pattern

    Carnegie Mellon University secured a 28.5 million dollar ARPA-H award for the LIVE project, developing 3D-printed human liver patches.

  5. Same pattern

    Aspect Biosystems has expanded its partnership with Novo Nordisk to develop bioprinted islet therapies for Type 1 diabetes.

  6. This article

    ARPA-H has awarded 25 million dollars to the VITAL project to develop 3D printed, patient-derived vascularized livers through a collaboration between UT Southwestern and Trestle Biotherapeutics.

  7. Same pattern

    Nanochon secured $4.1M in funding to launch first-in-human trials for its 3D-printed knee implant.